Top compounds associated with response to MADD


Feature Type Standardized
Nominal ANOVA
mRNA Midostaurin GDSC1000 pan-cancer AAC -0.15 7e-05
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 8e-05
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.13 0.0001
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.13 0.0001
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA AR-42 GDSC1000 pan-cancer AAC 0.12 0.0002
Download CSV